Glycopyrrolate and Prolonged expiration - a phase IV clinical study of FDA data

Summary:

Prolonged expiration is reported as a side effect among people who take Glycopyrrolate (glycopyrrolate), especially for people who are female, 60+ old, also take Prednisone, and have Eczema.

The phase IV clinical study analyzes which people have Prolonged expiration when taking Glycopyrrolate. It is created by eHealthMe based on reports of 5,510 people who have side effects when taking Glycopyrrolate from the FDA, and is updated regularly.

What is Glycopyrrolate?

Glycopyrrolate has active ingredients of glycopyrrolate. It is often used in hyperhidrosis. eHealthMe is studying from 5,599 Glycopyrrolate users. Check the latest studies of Glycopyrrolate.

What is Prolonged expiration?

Prolonged expiration (person's difficulty in breathing) is found to be associated with 83 drugs and 78 conditions by eHealthMe. Check the latest studies of Prolonged expiration.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

5,510 people reported to have side effects when taking Glycopyrrolate.
Among them, 117 people (2.12%) have Prolonged expiration.

Could Glycopyrrolate cause Prolonged expiration?

Among these 117 people:

What is the gender of people who have Prolonged expiration when taking Glycopyrrolate? *

Click here to view

What is the age of people who have Prolonged expiration when taking Glycopyrrolate? *

Click here to view more results

* Approximation only. Some reports may have incomplete information.

Do you take Glycopyrrolate and have Prolonged expiration?

- Check whether Prolonged expiration is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Glycopyrrolate:

Glycopyrrolate (5,599 reports)

Prolonged expiration treatments and more:

Prolonged expiration (396 reports)

How severe was Prolonged expiration and when was it recovered:

Prolonged expiration in Glycopyrrolate

Expand to all the drugs that have ingredients of glycopyrrolate:

Prolonged expiration and drugs with ingredients of glycopyrrolate

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Glycopyrrolate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Prolonged expiration:

Prolonged expiration (83 drugs)

Browse all the conditions that are associated with Prolonged expiration:

Prolonged expiration (78 conditions)

Related publications that referenced our studies

D'souza S, Gowler V, "Glycopyrrolate‐induced respiratory arrest: an unusual side effect", Acta Anaesthesiologica Scandinavica, 2015 Mar .
D'souza S, Gowler V, "Glycopyrrolate‐induced respiratory arrest: an unusual side effect", Acta Anaesthesiologica Scandinavica, 2015 Mar .

How the study uses the data?

The study uses data from the FDA. It is based on glycopyrrolate (the active ingredients of Glycopyrrolate) and Glycopyrrolate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.